PERBANDINGAN MANFAAT TERAPI ANTIPLATELET KOMBINASI ASPIRIN DAN KLOPIDOGREL DENGAN ASPIRIN TUNGGAL PADA STROKE ISKEMIK DI RSUP Dr. SARDJITO YOGYAKARTA
Introduction: Percentage incidence of recurrent stroke within the first 30 days after the attack is 3-10% and the risk occurs in the first 6 months is 8.8%. Antiplatelet therapy in patients with ischemic stroke to prevent recurrent stroke. Differences in the results of previous studies related to th...
Main Authors: | , RISMI FATONI, , dr. Abdul Gofir, Sp.S(K) |
---|---|
Format: | Thesis |
Published: |
[Yogyakarta] : Universitas Gadjah Mada
2014
|
Subjects: |
Similar Items
-
HUBUNGAN ANTARA PEMBERIAN ASPIRIN PADA PASIEN STROKE ISKEMIK DENGAN GANGGUAN FUNGSI KOGNITIF DI RSUP Dr.SARDJITO
by: ISLAMEY, TALITHA AMBAR, et al.
Published: (2014) -
THE INCIDENCE OF STROKE IN RSUP DR. SARDJITO IN THE YEAR OF 2012 AND 2013
by: , IZHAR BIN ISMAIL, et al.
Published: (2014) -
Antiplatelet therapy: aspirin for asymptomatic atherosclerosis?
by: Patrono, C, et al.
Published: (2010) -
HUBUNGAN RESISTENSI ASPIRIN DAN HIPERTENSI PADA
PASIEN STROKE ISKEMIK BERULANG
by: , Feolistin Mience Pobas, et al.
Published: (2013) -
Tailored antiplatelet therapy can overcome clopidogrel and aspirin resistance - The BOchum CLopidogrel and Aspirin Plan (BOCLA-Plan) to improve antiplatelet therapy
by: Pepinghege Fenena, et al.
Published: (2011-01-01)